People
-
Bangladeshi pharmaceutical company Beximco Pharma has announced the resignation of Ahsanul Karim from the Board of Directors effective as April 3, 2013 and the appointment of Faheemul Huq as a Non-Executive Director. Beximco manufactures a… Read more . . .
-
Alexza Pharmaceuticals has hired Peter W. Schineller as its new Senior VP and Chief Commercial Officer, responsible for global commercialization of the company’s Adasuve Staccato inhaled loxapine. The FDA approved Adasuve for the treatment of… Read more . . .
-
Smartinhaler developer Nexus6 has raised NZ$1.6 million (US$1.34 million) from existing investors plus NZ$3 (US$2.5 million) from BioScience Managers, with additional funding expected to bring the total to NZ$5 million by the close of the… Read more . . .
-
Inhaled pharmaceutical company Prosonix has hired Cécile Miles as its Chief Business Officer. She had been Commercial Director, Europe for the Arrow Group, part of Watson (now Actavis) since May 2011. Prior to Arrow, she… Read more . . .
-
Pearl Therapeutics, which is developing several inhaled drugs, has announced that it has hired Michael Riebe as VP, Pharmaceutical Development and Research, effective immediately. Riebe, a past chair and current steering committee member of the… Read more . . .
-
Lars Borgström Consulting has joined the Medicon Valley Inhalation Consortium (MVIC), bringing the group of companies involved in inhalation product development in the Skåne-Copenhagen region to 14 members. Borgström, the first recipient of RDD’s Charles… Read more . . .
-
Discovery Laboratories has named John G. Cooper as President and CEO replacing W. Thomas Amick, who had been chairman of the board since March 2007 and CEO since October 2010. Cooper was Executive VP and… Read more . . .
-
Trimel Pharmaceuticals has named Tom Rossi as CEO to replace Bruce D. Brydon, who has stepped down as CEO. Rossi has been President of Trimel since he joined the company in August 2011 and also… Read more . . .
-
Alexza Pharmaceuticals has announced the appointment of J. Kevin Buchi to its board of directors. Buchi, who was Corporate Vice President, Global Branded Products at Teva Pharmaceutical Industries from October 2011 until May 2012, has… Read more . . .
-
Paul M. Young and Daniela Traini have moved from the Pharmacy Faculty at the University of Sydney to the Woolcock Institute of Medical Research (WIMR) in order to establish a new Respiratory Technology team at… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal